Chemotherapy for advanced ovarian cancer-Reference-Cited by-同舟云学术

Chemotherapy for advanced ovarian cancer

Published:1999-01-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Stewart Lesley¹,

Affiliation:

1. University of York; Centre for Reviews and Dissemination; York UK YO10 5DD

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD001418/fullpdf

Reference70 articles.

1. A randomised study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma;Aabo;European Journal of Cancer and Clinical Oncology,1985

2. Comparison of melphalan with cyclophosphamide, methotrexate and 5-fluorouracil in patients with ovarian cancer;Brodovsky;Cancer,1984

3. Controlled prospective trial of combination chemotherapy with cyclophosphamide, Adriamycin and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report;Bruckner;Cancer Treatment Reports,1979

4. A randomised comparison of melphalan versus melphalan plus hexamethylmelamine versus Adriamycin plus cyclophosphamide in ovarian carcinoma;Omura;Cancer,1983

5. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of Cytoxan, 5-fluorouracil and dactinomycin;Park;Cancer,1980

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC);Pleura and Peritoneum;2024-06-01

2. Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer;Nature Communications;2024-05-18

3. Relationships between CD34-, CD105- and bcl-2-Expression Levels and Contrast-Enhanced Ultrasound-Based Differential Diagnosis of Adnexal Tumours;Journal of Clinical Medicine;2023-11-28

4. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-04-18

5. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer;Cochrane Database of Systematic Reviews;2022-02-16